Percutaneous pulmonary valve implantation (PPVI) in non-obstructive right ventricular outflow tract: limitations and mid-term outcomes

被引:9
|
作者
Esmaeili, Anoosh [1 ]
Khalil, Markus [2 ]
Behnke-Hall, Kachina [1 ]
Gonzalez y Gonzalez, Maria Belen [1 ,2 ]
Kerst, Gunter [3 ]
Fichtlscherer, Stephan [4 ]
Akintuerk, Hakan [2 ]
Schranz, Dietmar [1 ,2 ]
机构
[1] Goethe Univ, Pediat Heart Ctr Hessen, Frankfurt, Germany
[2] Justus Liebig Univ, Pediat Heart Ctr Hessen, Giessen, Germany
[3] Univ Hosp RWTH, Dept Pediat Cardiol, Aachen, Germany
[4] Goethe Univ, Div Cardiol, Dept Internal Med, Frankfurt, Germany
关键词
Native right ventricular outflow tract (native RVOT); percutaneous pulmonary valve implantation; pulmonary regurgitation (PI); mid-term follow-up; CONGENITAL HEART-DISEASE; RISK-FACTORS; REPLACEMENT; TETRALOGY; FALLOT; CONDUIT; REPAIR; REGURGITATION; EXPERIENCE;
D O I
10.21037/tp.2019.04.02
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: Percutaneous pulmonary valve implantation (PPVI) has been established as a safe and effective alternative to surgery treating patients with a failing pulmonary valve conduit. Nevertheless, the majority of patients in need of a valve have a native, non-obstructive right ventricular outflow tract (RVOT). The current approved stent-valves have a balloon-expandable design. Pre-stenting of the RVOT to create a landing zone and also protect the valve stability is usually mandatory; large, non-obstructive RVOTs need pre-stenting to reduce the RVOT-diameter for a balloon-expandable valve implantation. Methods: A retrospective study design was used to analyze the medium-term outcome after PPVI in a series of 26 patients with native or reconstructed RVOT. Results: PPVI was successfully performed in all, but 1 (96%). Within the follow-up of a minimum of 2 years, the percutaneous implanted valves remained competent; a significant pressure gradient was not detected. Furthermore, no PPVI-related complications such as endocarditis, migration or stent fractures were observed. The electrocardiogram at rest, in particular the QRS duration remained unchanged immediate post-PPVI as well as at medium-term follow-up of 24 months. However, ventricular arrhythmias were documented in 3 patients (11.5%); all patients were successfully treated with antiarrhythmic drugs, utilizing metoprolol. A trial of an invasive catheter based RVOT-ablation in one remained unsuccessful; pre-stented RVOT did not allow a successful intervention. Conclusions: Medium-term follow-up showed excellent results of the mechanical valve function. PPVI utilizing balloon-expandable stent-valves in a native RVOT remains an off-label use. Despite our encouraging results, advanced manipulations of the patched or native RVOT might be associated with significant ventricular arrhythmias. There is a need for less invasive RVOT reduction devices.
引用
下载
收藏
页码:107 / 113
页数:7
相关论文
共 50 条
  • [31] Percutaneous right outflow tract valve implantation: substrate matters
    Brugada, G. Sarquella
    Kammache, I.
    Iserin, L.
    Fraisse, A.
    Boudjemline, Y.
    EUROPEAN HEART JOURNAL, 2010, 31 : 637 - 637
  • [32] Percutaneous pulmonary valve replacement in a large right ventricular outflow tract - An experimental study
    Boudjemline, Y
    Agnoletti, G
    Bonnet, D
    Sidi, D
    Bonhoeffer, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (06) : 1082 - 1087
  • [33] Percutaneous pulmonary valve replacement in large right ventricular outflow tract: An experimental study
    Boudjemline, Y
    Agnoletti, G
    Bonnet, D
    Sidi, D
    Bonhoeffer, P
    PEDIATRIC RESEARCH, 2003, 53 (04) : 32A - 32A
  • [34] Percutaneous Pulmonary Valve Implantation in Patients With Right Ventricular Outflow Tract Dysfunction: A Systematic Review and Meta-Analysis.
    Ran Liyu
    Wang Wuwan
    Huang Wei
    CIRCULATION, 2018, 138
  • [35] The potential impact of percutaneous pulmonary valve stent implantation on right ventricular outflow tract re-intervention - Discussion
    Pepper, J
    Tsang
    Bhan, A
    Monro, J
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (04) : 543 - 543
  • [36] Three-dimensional printing in vitro simulation of percutaneous pulmonary valve implantation in large right ventricular outflow tract
    Valverde, Israel
    Sarnago, Fernando
    Prieto, Raquel
    Zunzunegui, Jose Luis
    EUROPEAN HEART JOURNAL, 2017, 38 (16) : 1262 - 1263
  • [37] Implantation of endovascular stents for the obstructive right ventricular outflow tract
    Sugiyama, H
    Williams, W
    Benson, LN
    HEART, 2005, 91 (08) : 1058 - 1063
  • [38] Is It Necessary to Pre-Stent Right Ventricular Outflow Tract Prior to Percutaneous Pulmonary Valve Implantation in All Patients?
    Turner, Daniel R.
    Thatte, Nikhil M.
    Gupta, Pooja
    Aggarwal, Sanjeev
    Singh, Harinder
    Forbes, Thomas J.
    Gowda, Srinath T.
    CIRCULATION, 2013, 128 (22)
  • [39] Percutaneous pulmonary valve implantation in patients with right ventricular outflow tract dysfunction: a systematic review and meta-analysis
    Ran, Liyu
    Wang, Wuwan
    Secchi, Francesco
    Xiang, Yajie
    Shi, Wenhai
    Huang, Wei
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10
  • [40] Pericardial neosinus creation for surgical treatment of right ventricular outflow tract: mid-term results
    Temizkan, Veysel
    Ugur, Murat
    Ucak, Alper
    Yilmaz, Ahmet Turan
    TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2013, 21 (04): : 892 - 897